CXCL12 and gastric cancer: The results of clone formation and transwell assays showed that the addition of the CXCL12/CXCR4 signaling pathway by the inhibitor, AMD3100, reverses the increase in the proliferation and migration of gastric cancer cells that was caused by KDM6B ectopic expression (Fig. 6C, D).